Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/1997
05/02/1997EP0769946A1 Methods of maintaining teeth and oral bone
05/01/1997WO1997015592A1 Novel human cysteine protease
05/01/1997WO1997015567A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them
05/01/1997WO1997015561A1 Chiral methyl phenyl oxazolidinones
05/01/1997WO1997015289A1 Solubilisation methods
05/01/1997CA2235575A1 Novel human cysteine protease
05/01/1997CA2235487A1 Solubilisation methods
05/01/1997CA2229617A1 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation
05/01/1997CA2188634A1 1ó,26 dihydroxy-d-homo-vitamin d3
04/1997
04/30/1997CN1148500A Medicine for quickly curing osteoproliferation
04/30/1997CN1034733C Spiro piperidines and homologs which promote release of growth hormone
04/29/1997US5624940 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof
04/24/1997WO1997014716A1 Cyclopeptide derivatives
04/24/1997WO1997014429A1 Stable pharmaceutical forms of administration containing parathormone
04/24/1997WO1997014376A1 Bone grafting matrix
04/24/1997WO1997009348A3 Orphan receptor
04/24/1997DE19540475A1 Chirale Methylphenyloxazolidinone Chiral methylphenyloxazolidinones
04/24/1997DE19538741A1 Cyclopeptidderivate Cyclopeptide derivatives
04/24/1997DE19538687A1 Stabile pharmazeutische Darreichungsformen enthaltend Parathormon The stable pharmaceutical dosage forms containing parathyroid hormone
04/24/1997CA2234724A1 Stable pharmaceutical forms of administration containing parathyroid hormone
04/23/1997CN1148341A Oral liquid alendronate formulations
04/23/1997CN1147961A Stable liquid composition containing urate oxidase and lyophilized composition for its prepn.
04/22/1997US5622987 Prevent migration or proliferation of smooth muscle cells
04/22/1997US5622982 Enzyme inhibitors; antiinflammatory agents
04/22/1997US5622941 Administering the dosage form, nontoxic activated vitamin d; sustain release, side-effect reducation
04/22/1997US5622721 Dosage forms of risedronate
04/17/1997WO1997013781A2 Synthetic peptides that inhibit il-6 activity
04/17/1997WO1997013764A1 Lipophilic benzothiophenes
04/17/1997CA2234267A1 Lipophilic benzothiophenes
04/17/1997CA2187850A1 Physiologically active ei-1941 compounds
04/16/1997EP0768306A1 Physiologically active hydrogenated benzopyran compounds
04/16/1997EP0767792A1 Vitronectin receptor antagonists
04/16/1997EP0656780B1 Drugs containing diphosphonic acids and salts thereof
04/15/1997US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain
04/15/1997US5621009 Chondroprotective agents
04/15/1997US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases
04/15/1997CA2110410C Therapeutic compositions for osteoinduction
04/10/1997WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE
04/10/1997WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
04/10/1997WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity
04/10/1997CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
04/09/1997EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
04/09/1997EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
04/09/1997EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar)
04/09/1997CN1147254A Prodrugs of morpholine tachykinin receptor antagonists
04/09/1997CN1034497C Process for preparation of aromatic amino-alcohol derivs. having antidiabetic and anti-obesity properties
04/08/1997US5618835 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
04/08/1997US5618558 Fatty acid treatment
04/08/1997US5618549 Bone diseases such as osteoporosis
04/03/1997WO1997012036A2 Bone stimulating factor
04/03/1997WO1997011718A1 Inhibitors of integrin receptors and their therapeutical uses
04/03/1997WO1997011692A2 Protein tyrosine kinase inhibitors for treating osteoarthritis
04/03/1997CA2233138A1 Inhibitors of integrin receptors and their therapeutical uses
04/02/1997EP0765668A1 Extract of Iridaceas and composition containing it
04/02/1997EP0573465B1 Therapeutic compositions to protect and resuscitate mammalian cells and methods for preparing and using same
04/02/1997CN1146355A Dianyansan powder medicine for acute waist sprain and preparation method thereof
04/02/1997CN1146352A Gujinkang traditional Chinese medicine and preparation method
04/02/1997CN1146343A External compress paste for discopathy
04/01/1997US5616560 Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
03/1997
03/27/1997WO1997011053A1 Calcitriol derivatives and their uses
03/26/1997EP0764645A1 Novel 3,4-diaryl furans and analogs thereof having use as anti-inflammatory agents
03/26/1997EP0764644A1 Use of medicaments containing 3,4-diaryl furans and analogs thereof for treating a gastrointestinal condition
03/26/1997EP0764208A1 Bmp-9 compositions
03/26/1997EP0764204A1 HUMAN OXALYL-CoA DECARBOXYLASE
03/26/1997EP0559751B1 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth)
03/26/1997CN1146152A Use of bisphophonates for inhibiting bone resorption following
03/25/1997US5614649 Treatment of muscular disorders, substituted guanidines
03/25/1997US5614625 Collagenase inhibitors
03/25/1997US5614535 Adhesion receptor antagonists
03/25/1997US5614531 Adhesion receptor antagonists
03/25/1997US5614513 Release agent binder for vitamin d compounds and derivatives
03/25/1997US5614496 Use of fibroblast growth factors to stimulate bone growth
03/25/1997US5614213 Use of estriol for treatment of climacteric osteoporosis
03/20/1997WO1997010219A1 Benzimidazole derivatives and their use in the prevention and/or the treatment of bone diseases
03/20/1997WO1997009992A1 Lipid extract having anti-inflammatory activity
03/19/1997EP0763055A1 Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
03/19/1997EP0763039A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
03/19/1997EP0762883A1 Pyridylbisphosphonates for use as a therapeutical agent
03/19/1997EP0762882A1 Vitronectin receptor antagonists
03/19/1997CN1145251A Pill for removing rheumatism
03/19/1997CN1145246A Chinese medicine "Juhongdan" for bone wound
03/18/1997US5612356 Retinoid antagonists
03/18/1997US5612349 Enantiomerically pure hydroxylated xanthine compounds to treat shock symptoms
03/13/1997WO1997009348A2 Orphan receptor
03/13/1997WO1997009056A1 Extract of iridaceae and compositions containing such extract
03/13/1997WO1997009044A1 Pentacyclic compounds, intermediates, processes, compositions, and methods
03/13/1997WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis
03/13/1997CA2230974A1 Pentacyclic compounds, intermediates, processes, compositions, and methods
03/12/1997EP0761669A2 Pentacyclic compounds, intermediates, processes, compositions, and methods
03/12/1997EP0761659A1 Naphthyl and dihydronaphthyl compounds as medicaments
03/12/1997EP0760658A1 Compounds for inhibiting osteoclast-mediated bone resorption
03/12/1997EP0760598A1 Meniscal augmentation device
03/12/1997CN1144667A Powder medicine for setting broken bone and its usage
03/11/1997US5610178 Macrolides and the use thereof
03/11/1997US5610168 Methods of use for inhibiting bone loss and lowering serum cholesterol
03/06/1997WO1997008174A1 Interleukin converting enzyme and apoptosis
03/06/1997WO1997007828A1 Therapy for cellular accumulation in chronic inflammatory diseases
03/06/1997WO1997007815A2 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
03/06/1997WO1997007805A1 Interleukin converting enzyme and apoptosis
03/06/1997WO1997005285A3 Methods and compositions for identifying morphogen analogs